• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911320220
Device Problem Occlusion Within Device (1423)
Patient Problems Non specific EKG/ECG Changes (1817); Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Reocclusion (1985); Chest Tightness/Pressure (2463)
Event Date 12/29/2014
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: the complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as mdr id# 2134265-2015-05560, 2134265-2015-05557, 2134265-2015-05554, 2134265-2015-05553.Pe-prove clinical study it was reported that stent thrombosis and myocardial infarction occurred.In (b)(6) 2010, the patient was referred for cardiac catheterization which revealed the 90% stenosed, de novo target lesion located in the 1st left posterolateral branch segment (lpl) of the left coronary artery that was 12mm long with a reference vessel diameter of 2.25mm.The target lesion was treated with predilatation and placement of a 2.25 x 20mm promus element stent resulting to 0% residual stenosis.One day post index procedure, the patient was discharged on aspirin and prasugrel.In (b)(6) 2014, the patient's cardiac enzymes were found to be elevated and the site reported an event of myocardial infarction (mi).The patient was subsequently hospitalized on the same day.Ecg was performed and the patient was referred for coronary angiography which revealed 50-75% in-stent restenosis in the small postero-lateral branch, in-stent restenosis in the mid segment of the right coronary artery (rca) and 75% stent thrombosis with complete occlusion of the promus element stents in the distal rca which were implanted in (b)(6) 2010.On the same day, stent thrombosis of the previously implanted promus element stents were treated with thrombus aspiration and implantation of a 2.25 x 11mm non-bsc stent at the origin of the right posterior descending segment of rca, a 2.50 x 24mm stent in the right lpl branch and a 3.50 x 18mm stent in the mid rca.The event was then considered resolved without residual effects.(b)(6) post procedure, the patient was discharged.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Same case as mdr id# 2134265-2015-05560, 2134265-2015-05557, 2134265-2015-05554, 2134265-2015-05553.It was further reported that in (b)(6) 2014, the patient experienced sudden tightness in the chest with no radiation or dyspnea.The patient contacted the emergency doctor immediately and was subsequently hospitalized.Ecg revealed st elevation.The patient was discharged on aspirin and prasugrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5018042
MDR Text Key23560853
Report Number2134265-2015-05559
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Report Date 07/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/19/2011
Device Model NumberH7493911320220
Device Catalogue Number39113-2022
Device Lot Number13487062
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/11/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-